Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology
Author:
Affiliation:
1. Leap Therapeutics; Cambridge MA USA
2. The F. M. Kirby Neurobiology Center, Boston Children's Hospital, Department of Neurology; Harvard Medical School; Boston MA USA
Funder
Boston Children's Hospital Intellectual and Developmental Disabilities Research Center
National Institutes of Health
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13894/fullpdf
Reference162 articles.
1. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer;Aguilera;Oncogene,2006
2. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer;Aguilera;Oncotarget,2015
3. Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6;Ahn;Dev Cell,2011
4. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors;Alexander;Br J Pharmacol,2015a
5. The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors;Alexander;Br J Pharmacol,2015b
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative in silico analysis of CHIR99021, Azakenpaullone and Tricantin interactions with GSK3(3, a key protein in stem cell fates;J COMPUT APPL MECH;2024
2. Knockdown of WISP1/DKK1 restrains phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial–mesenchymal transition and stemness;Clinical and Translational Oncology;2024-08-02
3. Dysfunction of dendritic cells in tumor microenvironment and immunotherapy;Cancer Communications;2024-07-25
4. Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis;PLOS ONE;2024-06-07
5. Targeted Agents in Esophagogastric Cancer Beyond Human Epidermal Growth Factor Receptor-2;Hematology/Oncology Clinics of North America;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3